Researchers at Kumamoto University have demonstrated that lysine-specific demethylase 1 (LSD1) shapes the variation in metabolic phenotypes seen in distinct […]
With drug discovery being an expensive process and genetic-based drugs being more likely to succeed, the level of investment in […]
A recent study has explored the concept of a modern and collaborative approach to data-driven drug development called Translational Precision […]
Recent DNA/RNA sequencing and other multi-omics technologies have advanced our understanding of the biology and pathophysiology of Alzheimer’s disease. However, […]
Despite an increase in investment into R&D from biopharma companies, only 5-10% of drugs that enter early-stage clinical trials ever […]
A recent article, published in Communications Biology, has outlined a method for expanding our understanding of host-microbiome interactions that will […]
With the advent of high-throughput techniques, we have a greater capability than ever before to study a diverse range of […]
Genetic and epigenetic changes underpin the development of a plethora of biological conditions that can be acquired over the course […]
Varenka Rodriguez DiBlasi, Exploratory Bioinformatics Lab Head of Cancer Immunology at Boehringer Ingelheim, shared a case study at D4 USA […]
D4 Europe is packed with case studies, evidence and intelligence that you can take back to your organisation and impact […]
